📰 Given Repligen News
Given Repligen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Repligen. Real-time updates on events, politics, business and more.
April 19, 2024
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Insider & Institutional Ownership 92.6% of Neurocrine Biosciences shares […]
January 1, 2024
Repligen (NASDAQ:RGEN – Get Free Report) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Analyst Recommendations This is a breakdown of current ratings […]
September 3, 2023
Psykey (OTCMKTS:CEOS – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Valuation & Earnings This table compares Psykey and Repligen’s revenue, […]
April 10, 2023
Repligen (NASDAQ:RGEN – Get Rating) and Molecular Partners (NASDAQ:MOLN – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. Institutional and Insider Ownership 91.0% of Repligen shares are held by […]